BioSpace News Archive

The industry analysis report is considered a valuable source of information about the global Tracheostomy Tube industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The French authorities validate the start of the therapeutic trial to evaluate the safety of the ExOlin® device for patients suffering from poorly controlled type 1 diabetes with severe glycaemic fluctuations and prone to severe hypoglycaemia.

On January 19, 2022 , Maxim Biomedical (MaximBio) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for their new ClearDetect™ COVID-19 Antigen Home Test ( ClearDetect™ ).

Nippon Shinyaku Co., Ltd. announced today that Nippon Shinyaku and Capricor Therapeutics (Headquarters: California, USA, CEO: Linda Marbán, NASDAQ: CAPR) have entered into an exclusive distribution agreement for CAP-1002 for the treatment* of Duchenne muscular dystrophy (DMD) in the territory of US.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its fourth quarter and year-end 2021 financial results conference call and webcast for 5:00 a.m. Pacific Time ( 8:00 a.m. Eastern Time ) on Friday, February 11, 2022.

The Board of Directors of BD has declared a quarterly dividend of $0.87 per common share, payable on March 31, 2022 to holders of record on March 10, 2022.

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter and full year 2021 operating results on Wednesday, February 23, 2022 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system diseases, today announced the dosing of the first human subjects in a Phase 1 clinical trial of its compound, CVN766.

The global Craniomaxillofacial Devices Market is expected to reach USD 3.92 Billion by 2027, according to a new report by Emergen Research.

The Global NGS Sample Preparation Market size is projected to reach USD 6.63 billion in 2027.